Welcome to Biotech Outsourcing Strategies 2017, the partnering event for stakeholders of pharmaceutical R&D outsourcing.
Established in 2006 and now in our 12th consecutive year, the scope of BOS 2017 will cover discovery, early CMC and clinical operations outsourcing. Our programme will include 2 tracks for Discovery/Early Development Outsourcing and Clinical Outsourcing respectively. Invited speakers will explore a broad scope of outsourcing relevant themes to include: Outsourcing Strategy and Business Process: Technical Operations: Quality and Regulatory aspects of Outsourcing: Supplier Relationship Management: Trends in Outsourcing: Outsourcing Case Studies: Services/Capabilities Showcase.
Who Should Attend BOS 2017?
Those leading and/or managing Discovery, Early CMC and Clinical outsourcing activities from academia, SME biotech, pharmaceutical companies and CROs/CMOs.
The BOS Event Formula
Partnering/Presentations/Exhibition/Informal Networking: These are the 4 key components around which BOS 2017 is built. Every attendee has access to our partnering software no later than 4 weeks before the event. Buyers from biotech and pharma have the opportunity to outline their outsourcing requirements using the online platform. Based on these requirements, attending CROs and CMOs are then able to send a meeting request and a 1 to 1 meeting will be scheduled during the event (provided the recipient accepts the meeting requests). This "partnering" element, which brings buyer and supplier together, is at the heart of BOS 2017 and a key resource in helping attendees connect.
In addition to the partnering, attendees will have access to our Exhibition, which will feature leading international CROs and CMOs. With these components, a comprehensive programme, and frequent opportunities for informal networking, BOS 2017 is a must attend event for stakeholders in R&D outsourcing. We look forward to welcoming you to the Royal College of Physicians, London.